Clinical trial
Chimeric Antigen Receptor-Modified T Cells for Breast Cancer
NCT02547961
Study timeline
Study start (actual)2015-09-01Date precision: month
Registry last updated2020-07-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
HER-2-targeting CAR T Cells infusionBIOLOGICAL
Sponsors & collaborators
Fuda Cancer Hospital, Guangzhoulead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02547961 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.